Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
1 minute read

Incyte Announced Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive Nonsegmental Vitiligo; Said Patients Treated With Povorcitinib Experienced Improvements In Total Body And Facial Repigmentation

By Charles Gross
Today, 6:54 AM
Incyte (Nasdaq: INCY) today announced new data from a Phase 2b clinical trial evaluating the safety and efficacy of povorcitinib (INCB54707), an investigational oral JAK1 inhibitor, in adult patients with extensive nonsegmental vitiligo.

INCY

Read More
1 minute read

Moody’s Earlier Downgraded First Republic Bank’s Ratings (Issuer Rating To B2 From Baa1) And Maintains Ratings Under Review For Downgrade

By Charles Gross
Today, 6:54 AM
Moody's Investors Service (Moody's) has today downgraded all long-term ratings and assessments of First Republic Bank (First Republic) and maintained the review for downgrade. First Republic's long-term issuer rating and local currency subordinate ratings were downgraded to B2 from Baa1, and preferred stock non-cumulative rating was downgraded to Caa1(hyb) from Baa3(hyb).

FRC